Network pharmacology-based analysis of the role of tacrolimus in liver transplantation

Network pharmacology-based analysis of the role of tacrolimus in liver transplantation

Background: Tacrolimus is a powerful immunosuppressant and has been widely used in organ transplantation. In order to further explore the role of tacrolimus in liver transplantation, we conducted network pharmacology analysis. Methods: GSE100155 was obtained from the GEO database, and the DEGs of li...

Full description

Bibliographic Details
Main Authors:	Lijian Chen, Yuming Peng, Chunyi Ji, Miaoxian Yuan, Qiang Yin
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Saudi Journal of Biological Sciences
Subjects:	Tacrolimus Network pharmacology GEO Liver transplantation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319562X20307154

Similar Items

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients
by: Choi HJ, et al.
Published: (2018-02-01)

Tacrolimus-induced parkinsonism in a patient after liver transplantation – case report
by: Karin Gmitterová, et al.
Published: (2018-04-01)

Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation
by: Chih-Yang Hsiao, et al.
Published: (2021-02-01)

An analysis of tacrolimus-related complications in the first 30 days after liver transplantation
by: Lucas Souto Nacif, et al.
Published: (2014-11-01)

Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation
by: Benas Prusinskas, et al.
Published: (2021-06-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01)

A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection
by: Eric M. Yoshida, M.D., M.H.Sc., FR.C.P.C., et al.
Published: (2013-03-01)

Early serum tacrolimus levels predict long-term chronic kidney disease after liver transplantation
by: Vanessa B. A. Brandão, et al.

P-116 PREGNANCY AFTER LIVER TRANSPLANTATION: OUTCOMES IN PERU
by: Bertha Cárdenas Ramírez, et al.
Published: (2021-09-01)

Clinical utility of ABCB1 single nucleotide polymorphism on tacrolimus dose requirements in Egyptian liver transplant patients
by: Azza Abd El-rahman Saab, et al.
Published: (2021-08-01)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
by: Sebastian C. B. Bremer, et al.
Published: (2018-11-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus
by: Mio Fukuda, et al.
Published: (2019-06-01)

Variations in Practice to Therapeutic Monitoring of Tacrolimus following Primary Adult Liver Transplantation
by: BVM Dasari, et al.
Published: (2016-01-01)

Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study
by: Rongrong Wang, et al.
Published: (2020-08-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01)

Temporary Parenteral Tacrolimus Requirement due to Unexplained Low Through Levels in a Liver Transplant Patient with Short Bowel Syndrome
by: V Ince, et al.
Published: (2014-01-01)

A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients
by: Krishna Asuri, et al.
Published: (2020-01-01)

Interactions between Tacrolimus and Metronidazole in a renal transplant patient
by: Catic-Djordjevic Aleksandra, et al.
Published: (2012-10-01)

Therapeutic drug monitoring of tacrolimus in pancreas transplantation at São Lucas Hospital Monitoramento terapêutico de tacrolimus em transplante de pâncreas no Hospital São Lucas
by: Luciana Mello de Oliveira, et al.
Published: (2007-10-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Tablet or capsule form of generic mycophenolate mofetil (My-Rept®) after liver transplantation: a prospective randomized trial
by: Kim JM, et al.
Published: (2019-07-01)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)

Post-liver transplantation immonusuppression: main principles and modern implementation
by: Kakharman Yesmembetov, et al.
Published: (2018-09-01)

Anemia hemolítica microangiopática induzida por tacrolimus e ciclosporina A Microangiopathic hemolytic anemia induced by tacrolimus and ciclosporine A
by: Rafael S. Vasconcelos, et al.
Published: (2008-12-01)

Real-World Administration of Once-Daily MeltDose<sup>®</sup> Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
by: Katharina Willuweit, et al.
Published: (2021-12-01)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Tacrolimus as a rare cause of pericardial effusion in a renal transplant recipient
by: Rohini Prashar, et al.
Published: (2017-01-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
by: Arnaud Del Bello, et al.
Published: (2021-10-01)

Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients
by: Marwa Helal, et al.
Published: (2017-07-01)

Tacrolimus Induced Diabetic Ketoacidosis Following Allogeneic Stem Cell Transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01)